Catalyst Pharmaceuticals Inc (CPRX)
16.44
+0.32 (+1.99%)
USD |
NASDAQ |
Mar 27, 16:00
16.59
+0.15 (+0.91%)
After-Hours: 20:00
Catalyst Pharmaceuticals Cash and Short Term Investments (Quarterly): 298.40M for Dec. 31, 2022
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2022 | 298.40M |
| September 30, 2022 | 256.06M |
| June 30, 2022 | 220.79M |
| March 31, 2022 | 197.80M |
| December 31, 2021 | 191.27M |
| September 30, 2021 | 174.79M |
| June 30, 2021 | 155.28M |
| March 31, 2021 | 143.30M |
| December 31, 2020 | 140.28M |
| September 30, 2020 | 127.11M |
| June 30, 2020 | 115.05M |
| March 31, 2020 | 101.75M |
| December 31, 2019 | 94.52M |
| September 30, 2019 | 76.54M |
| June 30, 2019 | 59.92M |
| March 31, 2019 | 45.63M |
| December 31, 2018 | 53.48M |
| September 30, 2018 | 61.66M |
| June 30, 2018 | 68.41M |
| March 31, 2018 | 77.94M |
| December 31, 2017 | 84.01M |
| September 30, 2017 | 33.91M |
| June 30, 2017 | 35.13M |
| March 31, 2017 | 36.53M |
| December 31, 2016 | 40.41M |
| Date | Value |
|---|---|
| September 30, 2016 | 44.74M |
| June 30, 2016 | 48.02M |
| March 31, 2016 | 52.45M |
| December 31, 2015 | 58.40M |
| September 30, 2015 | 62.96M |
| June 30, 2015 | 67.40M |
| March 31, 2015 | 71.54M |
| December 31, 2014 | 39.28M |
| September 30, 2014 | 41.45M |
| June 30, 2014 | 45.01M |
| March 31, 2014 | 21.28M |
| December 31, 2013 | 23.71M |
| September 30, 2013 | 27.65M |
| June 30, 2013 | 11.37M |
| March 31, 2013 | 13.16M |
| December 31, 2012 | 15.42M |
| September 30, 2012 | 11.97M |
| June 30, 2012 | 7.515M |
| March 31, 2012 | 4.723M |
| December 31, 2011 | 6.029M |
| September 30, 2011 | 2.151M |
| June 30, 2011 | 3.406M |
| March 31, 2011 | 6.873M |
| December 31, 2010 | 5.475M |
| September 30, 2010 | 6.247M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
45.63M
Minimum
Mar 2019
298.40M
Maximum
Dec 2022
133.00M
Average
121.08M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| ADMA Biologics Inc | 86.52M |
| Ardelyx Inc | 123.91M |
| Rhythm Pharmaceuticals Inc | 333.29M |
| Merrimack Pharmaceuticals Inc | 19.44M |
| Jaguar Health Inc | 10.56M |